MyAverix Finance
NS · Biotechnology
Advanced Enzyme Technologies Ltd (ADVENZYMES)
Pharmaceuticals & Biotechnology
Advanced Enzyme Technologies Ltd (ADVENZYMES) is listed on NS in the Biotechnology sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-07, reported market cap is $42.03B, P/E ratio is 31.88, net margin is 25.3%, dividend yield is 0.32%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ADVENZYMES
Advanced Enzyme Technologies Ltd (ADVENZYMES) — FAQ
What is Advanced Enzyme Technologies Ltd's market cap?
Advanced Enzyme Technologies Ltd (ADVENZYMES) has a reported market cap of $42.03B (data as of 2026-07-07).
What is ADVENZYMES's P/E ratio?
The price-to-earnings (P/E) ratio for Advanced Enzyme Technologies Ltd (ADVENZYMES) is 31.88 (data as of 2026-07-07).
Does Advanced Enzyme Technologies Ltd pay a dividend?
Advanced Enzyme Technologies Ltd (ADVENZYMES) shows a reported dividend yield of 0.32%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-07).
What sector is Advanced Enzyme Technologies Ltd in?
Advanced Enzyme Technologies Ltd (ADVENZYMES) is classified in the Biotechnology sector (Pharmaceuticals & Biotechnology industry).
What exchange is ADVENZYMES listed on?
ADVENZYMES is listed on NS.
What is Advanced Enzyme Technologies Ltd's net margin?
Advanced Enzyme Technologies Ltd (ADVENZYMES) reports a net margin of 25.3% (data as of 2026-07-07).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.